Julie Hong Selected Research

Julie Hong Research Topics

7	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 01/2021
3	Psoriatic Arthritis 01/2022 - 01/2021
2	Fetal Death 01/2021 - 01/2021
2	Hemorrhage 01/2021 - 01/2021
1	Ankylosing Spondylitis 01/2022
1	Body Dysmorphic Disorders (Body Dysmorphic Disorder) 09/2021
1	Nail Diseases (Nail Disease) 06/2021
1	Appendicitis 01/2021
1	Chorioamnionitis 01/2021
1	Gallbladder Diseases (Gall Bladder Disease) 01/2021
1	Hyperplasia 01/2021
1	Sepsis (Septicemia) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Neoplasm Metastasis (Metastasis) 01/2017
1	Neoplasms (Cancer) 06/2002
1	Adenocarcinoma 03/2002
1	Margins of Excision 03/2002

2	EpitopesIBA 01/2022 - 01/2022
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2017
2	Biological ProductsIBA 10/2021 - 01/2021
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 10/2021
1	Pharmaceutical PreparationsIBA 10/2021
1	7,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA 09/2021
1	Biological FactorsIBA 09/2021
1	Interleukin-23 (Interleukin 23)IBA 06/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2021
1	CytokinesIBA 01/2021
1	Ustekinumab (CNTO 1275)FDA Link 01/2021
1	InterleukinsIBA 01/2021
1	HLA-C Antigens (HLA-C)IBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	CollagenIBA 01/2017
1	Integrin alpha1IBA 01/2017
1	Prostate-Specific Antigen (Semenogelase)IBA 03/2002

5	Therapeutics 06/2021 - 01/2017
2	Cesarean Section (Caesarean Section) 01/2021 - 01/2021
2	Length of Stay 01/2021 - 01/2021
2	Prostatectomy (Retropubic Prostatectomy) 06/2002 - 03/2002
1	Injections 06/2021
1	Phototherapy (Light Therapy) 06/2021
1	Appendectomy 01/2021
1	Cholecystectomy 01/2021
1	Patient Readmission 01/2021
1	Laparoscopic Cholecystectomy 01/2021
1	Adjuvant Radiotherapy 03/2002